mRNA vaccine targeting hemagglutinin glycoprotein (Acuitas Therapeutics/University of Pennsylvania)

N/A

Report date: 2026/01/26 17:59:09

Base Information

Drug NamemRNA vaccine targeting hemagglutinin glycoprotein (Acuitas Therapeutics/University of Pennsylvania)
Drug Alias Nameinfluenza A vaccine (Acuitas Therapeutics/University of Pennsylvania)mRNA-based Influenza A vaccine (Acuitas Therapeutics/University of Pennsylvania)H5 mRNA-LNP vaccineclade 2.3.4.4b H5 HA mRNA-LNP vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesAcuitas Therapeutics IncUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A